globulin/悪性腫瘍

TECHNICAL FIELD The present invention relates to novel peptides having tumor cell invasion-inhibiting activities, complexes of peptides having tumor cell invasion-inhibiting activities with polymers, and cancer metastasis inhibitors comprising them as active ingredients. BACKGROUND ART For the

FIELD OF THE INVENTION The present invention refers to the treatment of cancer and, more particularly, it is related to a composition and a method of treating cancer, useful for involuting a carcinoma in any stage of evolution thereof. BACKGROUND OF THE INVENTION It has been fully recognized in

BACKGROUND OF THE INVENTION The present invention involves the diagnosis of bladder cancer comprising detection of a particular and unique proteinaceous urine component. Bladder cancer consists of a heterogenous group of tumors with varied capacities for invasion and metastasis. This disease

BACKGROUND OF THE INVENTION The present invention involves the diagnosis of bladder cancer comprising detection of a particular and unique proteinaceous urine component. Bladder cancer consists of a heterogenous group of tumors with varied capacities for invasion and metastasis. This disease

FIELD OF THE INVENTION The invention generally relates to the treatment of cancer, and, more specifically, to the treatment of tumors, including, but not limited to human sarcomas, melanomas, and carcinomas, including their metastases. Specifically it relates to a method for inducing cancer

FIELD OF INVENTION The present invention relates to immunotherapy and chemotherapy products and methods for treatment of hosts having cancer. PRIOR ART - IMMUNOTHERAPY A. Forced Flow Electrophoresis Forced flow electrophoresis is a technique whereby a gamma globulin rich fraction is

TECHINICAL FIELD OF THE INVENTION The present invention relates to cancer therapy and in particular to the administration of gamma globulins to inhibit metastasis and augment treatment of primary cancerous tumors. In accordance with this invention, the treatment of various cancerous diseases is

FIELD OF THE INVENTION The present invention relates to the use of a histamine-added gamma-globulin as pharmaceuticals. More particularly, it relates to an immunomodulating agent, a suppressive agent to hypereosinophilicity and an antiinflammatory agent containing the histamine-added gamma-globulin

FIELD OF THE INVENTION The present invention relates to the use of a histamine-added gamma-globulin as pharmaceuticals. More particularly, it relates to an immunomodulating agent, a suppressive agent to hypereosinophilicity and an antiinflammatory agent containing the histamine-added gamma-globulin

FIELD OF THE INVENTION Generally, the present invention relates to a diagnostic procedure and clinical test kit for determining the presence or absence of human chorionic gonadotropin hormone, a glycoprotein, in a cell specimen and thereby the absence of malignant neoplastic cells. The reason why a

FIELD OF THE INVENTION Generally, the present invention relates to a diagnostic procedure and clinical test kit for determining the presence or absence of human chorionic gonadotropin hormone, a glycoprotein, in a cell specimen and thereby the absence of malignant neoplastic cells. The reason why a

The present invention relates to forms of administration of dihydrotestosterone, DHT for short, whose therapeutic uses are many, and in particular the forms adapted for androgenotherapy, particularly in persons in danger of prostate hyperplasia, in particular benign hyperplasia. It has been

BACKGROUND OF INVENTION For the maintenance, and also for the division of cells, it is necessary for the cell to reproduce its genome (DNA), then to transcribe the genes (DNA) into various RNAs among which are messenger RNAs, which in turn direct the synthesis of proteins. The biological medium that

BACKGROUND OF THE INVENTION This patent application is related to the invention disclosed in copending, coassigned patent application Ser. No. 830,662 filed Feb. 18, 1986. This invention relates to compositions and methods employing the same for the treatment and healing of humans. In one embodiment